HG-1013

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHG-1013
Drug Alias NameCC-chemokine receptor chemr1 modulator (Human Genome Sciences)CKR-L1 modulator (Human Genome Sciences)CMKBRL2 modulator (Human Genome Sciences)CY6 modulator (Human Genome Sciences)GPR-CY6 modulator (Human Genome Sciences) +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 8 modulators
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsInflammationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A